BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• FDA

  FDA Clears Four New Coronary Micro Support Catheters

  Transit Scientific announced the FDA clearance of its XO Cross® Support Catheter Platform to include coronary use.

  April 12, 2022

   · 

  2 min read
• Business

  Vera Therapeutics Announces Appointment of Michael M. Morrissey, Ph.D., as Chairman of its Board of Directors

  Vera Therapeutics announced today the appointment Michael M. Morrissey, Ph.D., as chairman of its board of directors.

  April 12, 2022

   · 

  5 min read
• Pharm Country

  Aquestive Therapeutics Reports Positive Topline Data from Part 2 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film

  Aquestive Therapeutics, Inc. (NASDAQ: AQST), today announced positive topline results from Part 2 of the EPIPHAST study for its AQST-109 epinephrine oral film.

  April 12, 2022

   · 

  12 min read
• Recce Pharmaceuticals Announces Anti-Viral Patent Granted in Hong Kong for RECCE® Anti-Infectives

  Recce Pharmaceuticals Limited is pleased to announce the Intellectual Property Department of the Hong Kong Special Administrative Region has granted patent family three, “Anti-Virus Agent and Method for Treatment of Viral Infection,” furthering marketing and manufacturing exclusivity to February 2037.

  April 12, 2022

   · 

  3 min read
• PolyPid Announces Presentation of Clinical Data at Surgical Infection Society 2022 Annual Meeting

  PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that the Company will present clinical data at the upcoming Surgical Infection Society 2022 Annual Meeting, being held on April 23-26, 2022 in Dallas, TX.

  April 12, 2022

   · 

  1 min read
• Drug Development

  AbbVie Presents Positive Investigational Navitoclax Combination Data in Phase 2 REFINE Study Suggesting Anti-Fibrosis Activity for Patients with Myelofibrosis

  AbbVie (NYSE: ABBV) today announced new data from a Phase 2 trial of navitoclax in combination with ruxolitinib in patients with myelofibrosis.

  April 12, 2022

   · 

  8 min read
• Pharm Country

  Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference

  Enteris BioPharma, Inc. announced today that two submitted abstracts were accepted for poster presentations at the 104th annual meeting of The Endocrine Society (ENDO 2022) taking place June 11-14, 2022, in Atlanta, Georgia.

  April 12, 2022

   · 

  2 min read
• Business

  Melior Announces Substantial Additions to Its Management and Scientific Team

  Melior Discovery, Inc. (Melior) announced today significant additions to its management organization.

  April 12, 2022

   · 

  3 min read
• Drug Development

  APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting

  Aptevo Therapeutics Inc. today announced the presentation of preclinical data for APVO442 in a poster session at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, LA.

  April 12, 2022

   · 

  6 min read
• Drug Development

  Hoth Therapeutics Announces Acceptance to Present HT-ALZ Proof-of-Concept Alzheimer’s Disease Data at the 2022 Alzheimer’s Association International Conference

  Hoth Therapeutics, Inc. today announced acceptance to present the preclinical Alzheimer’s disease mouse model data of HT-ALZ.

  April 12, 2022

   · 

  4 min read